Class III — Low Risk

Low risk — use of or exposure to this product is not likely to cause adverse health consequences.

iontoPATCH On-the-Go Patch Therapy Recalled by Tapemark Company Due to The dosage information on the pouch is incorrect;...

Date: November 10, 2021
Company: Tapemark Company
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Tapemark Company directly.

Affected Products

iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery System, Extra Strength, 8-HOUR Average Wear Time, 6/1-patch pouches/box. Dosage: 120mA/min.

Quantity: 5,141 primary cartons

Why Was This Recalled?

The dosage information on the pouch is incorrect; the primary carton label is correct.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Tapemark Company

Tapemark Company has 1 total recall tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report